Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study (ATO-SR-DM)

This study has been completed.
Sponsor:
Collaborator:
American Diabetes Association
Information provided by:
Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier:
NCT00790530
First received: November 11, 2008
Last updated: NA
Last verified: November 2008
History: No changes posted
  Purpose

The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.


Condition Intervention
Diabetes Mellitus
Behavioral: Automated Telephone Outreach with Speech Recognition
Other: Usual Care

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study

Resource links provided by NLM:


Further study details as provided by Harvard Pilgrim Health Care:

Primary Outcome Measures:
  • Completion of dilated eye examination [ Time Frame: 12-months following intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Completion of glycated hemoglobin testing (HbA1c) [ Time Frame: one-year following intervention ] [ Designated as safety issue: No ]
  • Completion of LDL-cholesterol testing [ Time Frame: one year following intervention ] [ Designated as safety issue: No ]
  • Completion of microalbumin testing [ Time Frame: one-year following intervention ] [ Designated as safety issue: No ]

Enrollment: 1200
Study Start Date: June 2006
Study Completion Date: October 2007
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: ATO-SR
Automated Telephone Outreach with Speech Recognition
Behavioral: Automated Telephone Outreach with Speech Recognition
Automated Telephone Outreach with Speech Recognition
No Intervention: Usual Care
Usual Care
Other: Usual Care
Usual Care

Detailed Description:

Randomly allocate a total of 1200 health plan members with diabetes to automated telephone outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention is a series of three calls, using automated calls, originating from the health plan, using interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage participants to fulfill the recommended testing (dilated eye examinations, glycated hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the preceding year.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 18 years or older
  • Diabetes, defined as either 1) filled a prescription for insulin or an oral hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients encounter claims with an ICD9-CM or CPT code indicating diabetes.
  • Gap in a key diabetes management metric as evidenced by no claim for a dilated eye examination in the prior 15 months and no claim for one or more of the following tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with evidence of having received ACE-inhibitors or angiotensin receptor blockers were considered to have had a microalbumin test.)

Exclusion Criteria:

  • No primary care clinician in the data base
  • Those who had previously asked the health plan to exclude them from research or quality improvement
  • Women whose claim records contained diagnoses suggesting gestational diabetes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00790530

Locations
United States, Massachusetts
Harvard Pilgrim Health Care
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Harvard Pilgrim Health Care
American Diabetes Association
Investigators
Principal Investigator: Steven R Simon, MD Harvard Pilgrim Health Care
  More Information

No publications provided by Harvard Pilgrim Health Care

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Steven R. Simon, Principal Investigator, Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier: NCT00790530     History of Changes
Other Study ID Numbers: 1-05-JF-40
Study First Received: November 11, 2008
Last Updated: November 11, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by Harvard Pilgrim Health Care:
Diabetes
Information Technology
Health Plans

Additional relevant MeSH terms:
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on October 23, 2014